IPO Details - Sudeep Pharma Ltd.
Sudeep Pharma Ltd.
IPO

Sudeep Pharma Ltd.

Closed
NSE & BSE Bookbuilding IPO Face Value: ₹1.00 Lot Size: 25.00

Issue Price: ₹593.00 | Sale Type: Fresh Capital-cum-Offer for Sale

Grey Market Premium ₹113 per share
₹593.00
Issue Price
25.00
Lot Size
₹1.00
Face Value
19.06%
Est. Listing Gain

IPO Details

Issue Type: Bookbuilding IPO
Issue Price: ₹593.00
Lot Size: 25.00
Sale Type: Fresh Capital-cum-Offer for Sale
Face Value: ₹1.00
Listing Exchange: NSE & BSE
GMP: ₹113
Est. Listing: 2025-11-28

IPO Timeline

2025-11-21
IPO Opens for Subscription
2025-11-25
IPO Closes for Subscription
2025-11-28
Tentative Listing Date

About Company

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.

The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specializing in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium 

The company supplies more than 200 products to a diverse customer base across pharma, food, and nutrition sectors

The company has strong R&D capabilities with in-house labs and pilot-scale facilities focused on mineral salts and excipients.

Product Portfolio:

  • Pharmaceutical, Food and Nutrition Business
  • Specialty Ingredients Business
  • Triturates

As of December 31, 2024, the company had 704 permanent employees.

Competitve Strengths:

  • Market leadership with a diversified product portfolio in a high barrier industry
  • Distinguished global customer base with long-standing relationships with key customers
  • Well-equipped and regulatory compliant Manufacturing Facilities
  • Strong research and development capabilities

Company Information

Email
cs.sudeep@sudeepgroup.com
Phone
+91 265 284 0656

Registrar Information

Registrar
MUFG Intime India Pvt.Ltd.
Email
sudeeppharma.ipo@in.mpms.mufg.com